These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9229836)

  • 21. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment].
    Progonnaia VV
    Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458
    [No Abstract]   [Full Text] [Related]  

  • 23. [Calcium inhibitors and myocardial ischemia].
    Thuillez C
    Therapie; 1993; 48 Spec No():671-6. PubMed ID: 8091353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular drugs and exercise.
    Lowenthal DT; Kendrick ZV; Chase R; Paran E; Perlmutter G
    Exerc Sport Sci Rev; 1987; 15():67-94. PubMed ID: 2885201
    [No Abstract]   [Full Text] [Related]  

  • 25. [The single-dose screening of nitrates, calcium antagonists, beta-adrenoblockaders and their combinations in patients with stenocardia of effort by using the paired bicycle ergometry method].
    Kukushkin SK; Kokurina EV; Metelitsa VI; Bochkareva EV; Vygodin VA
    Ter Arkh; 1993; 65(4):43-9. PubMed ID: 7914712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
    Deedwania PC; Pool PE; Thadani U; Eff J
    Am J Cardiol; 1997 Aug; 80(4):421-5. PubMed ID: 9285652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
    Fukumoto Y; Yasuda S; Ito A; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):253-7. PubMed ID: 18356689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The clinical efficacy of diltiazem and the means for enhancing it in treating patients with ischemic heart disease combined with chronic bronchitis].
    Siurin AA; Ionov VA
    Kardiologiia; 1993; 33(3):20-2. PubMed ID: 8377333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The tourniquet test in evaluating the analgesic action of antianginal preparations].
    Zhiliaev EV; Glazunov AV
    Ter Arkh; 1993; 65(4):40-3. PubMed ID: 8059406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An evaluation of the efficacy of treating IHD patients with calcium antagonists].
    Mordovin VF; Triss SV; Fedorova NA; Chernov VI; Krylov A; Pavliukova EN; Karpov RS
    Ter Arkh; 1995; 67(6):5-8. PubMed ID: 7667781
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of a single administration of diltiazem on exercise tolerance in patients with stable angina pectoris].
    Meluzín J; Lupínek Z; Rysavý F
    Vnitr Lek; 1988 Oct; 34(10):942-9. PubMed ID: 3212946
    [No Abstract]   [Full Text] [Related]  

  • 32. [The chronobiological aspects of drug resistance to antianginal therapy].
    Arushanian EB; Shamliian TA
    Eksp Klin Farmakol; 1994; 57(4):33-5. PubMed ID: 7950781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
    Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
    Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
    Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
    Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
    [No Abstract]   [Full Text] [Related]  

  • 35. [New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].
    Kukushkin SK; Shamarin VM; Manoshkina EM; Berzak NV; Petrosian KIu
    Ter Arkh; 1996; 68(1):29-30. PubMed ID: 8644025
    [No Abstract]   [Full Text] [Related]  

  • 36. [New approaches to pharmacodynamic research on anti-angina agents].
    Metelitsa VI; Martsevich SIu; Slastnikova ID; Kokurina EV; Riabokon' OS
    Farmakol Toksikol; 1986; 49(5):56-9. PubMed ID: 3533620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations of diltiazem after oral administration in coronary artery disease patients: a comparison with those in normal volunteers.
    Koiwaya Y; Matsuguchi T; Nakamura M; Etoh A
    Clin Ther; 1981; 4(2):127-32. PubMed ID: 7296594
    [No Abstract]   [Full Text] [Related]  

  • 38. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.